Inclusive Capital to Sell 327 Million Euro Bayer Stake
Inclusive Capital is offering 8.5 million shares in Bayer AG via a stock placing. The sale follows a period of management and strategic shifts at the company.
Xurve View
Insights:
Xurve View
Inclusive Capital Partners is reportedly seeking to divest its stake in the Germany-based life sciences company Bayer AG. According to reports from Bloomberg News, the activist investor is offering roughly 8.5 million shares in a stock placement arranged by JPMorgan Chase & Co..
The proposed sale represents a stake valued at approximately 327 million euros, or $380.17 million, based on the most recent closing prices. Neither Inclusive Capital nor Bayer have issued official comments regarding the transaction.
